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Repression of mitochondrial respiration represents
an evolutionarily ancient cellular adaptation to
hypoxia and profoundly influences cell survival and
function; however, the underlying molecular mech-
anisms are incompletely understood. Primarily
utilizing pulmonary arterial endothelial cells as
a representative hypoxic cell type, we identify the
iron-sulfur cluster assembly proteins (ISCU1/2) as
direct targets for repression by the hypoxia-induced
microRNA-210 (miR-210). ISCU1/2 facilitate the as-
sembly of iron-sulfur clusters, prosthetic groups
that are critical for electron transport and mitochon-
drial oxidation-reduction reactions. Under in vivo
conditions of upregulating miR-210 and repressing
ISCU1/2, the integrity of iron-sulfur clusters is disrup-
ted. In turn, by repressing ISCU1/2 during hypoxia,
miR-210 decreases the activity of prototypical
iron-sulfur proteins controlling mitochondrial metab-
olism, including Complex I and aconitase. Conse-
quently, miR-210 represses mitochondrial respira-
tion and associated downstream functions. These
results identify important mechanistic connections
among microRNA, iron-sulfur cluster biology,
hypoxia, and mitochondrial function, with broad
implications for cellular metabolism and adaptation
to cellular stress.
INTRODUCTION
The processes that govern cellular adaptation to hypoxia are
complex and incompletely defined. One fundamental and highly
conserved response to hypoxia was originally described in the
nineteenth century by Louis Pasteur, who identified a metabolic
shift in hypoxic cells, later discovered to result from repression of
the tricarboxylic acid (TCA) cycle, mitochondrial electron trans-
port, and oxidative phosphorylation in favor of glycolysis (Aisen-
berg and Potter, 1957). This ‘‘Pasteur effect’’ profoundly influ-
ences cell survival and function in a variety of cell and tissueCelltypes, and is thought to optimize the efficiency by which energy
is generated (ATP) while avoiding excessive generation of toxic
reactive oxygen species (ROS) (Semenza, 2007). In particular,
this response may be especially important to the pulmonary
vascular endothelium, which directly responds to hypoxia by
controlling the release of vasoactive effectors, thereby critically
influencing normal vascular physiology and the development of
pulmonary hypertension (Stenmark et al., 2006).
The underlying molecular mechanisms of this highly coordi-
nated metabolic response are only beginning to be understood.
Hypoxia-inducible factor-1 alpha (HIF-1a), a master regulator of
the cellular hypoxic response, has been shown to control mito-
chondrial function (Chavez et al., 2008) and is essential for this
repression of mitochondrial respiration (Seagroves et al., 2001)
during hypoxia. Furthermore, a limited number of factors have
been identified that regulate shifts in hypoxic mitochondrial
respiration, including pyruvate dehydrogenase kinase (PDK1),
lactate dehydrogenase A (LDHA), cytochrome c oxidase (COX
subunits 4-1 and 4-2), and the mitochondrial protease LON (Se-
menza, 2007). However, owing to the still incompletely under-
stood nature of the interaction between HIF-1a and mitochon-
dria, we hypothesized that additional factors likely mediate this
fundamental metabolic event.
Endogenous microRNA molecules (miRNA) have been identi-
fied as essential mediators of numerous cellular processes,
potentially including the response to hypoxia (Ivan et al., 2008).
In particular, microRNA-210 (miR-210) is specifically induced
by HIF-1a during hypoxia (Kulshreshtha et al., 2007). The cell-
cycle regulator E2F3 (Giannakakis et al., 2008), the receptor tyro-
sine kinase ligand ephrin A3 (Fasanaro et al., 2008), and the DNA
repair protein RAD52 (Crosby et al., 2009) have been studied as
targets for repression by miR-210; however, the complete
functions of this miRNA have yet to be delineated. Because
miRNAs quickly and efficiently regulate posttranscriptional
changes in target gene expression, we hypothesized that this
HIF-1a-dependent miRNA represents an ideal factor that may
dynamically modulate mitochondrial metabolism.
By analysis of multiple bioinformatic algorithms, a highly
conserved binding site for miR-210 is predicted in the 30UTR of
the transcripts of the iron-sulfur cluster assembly proteins,
ISCU1 and ISCU2. In mammalian cells, two splice isoforms of
ISCU exist. Both transcripts carry an identical 30UTR, but they
differ in their location: ISCU1 is located in the cytosol, whereasMetabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc. 273
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In order to highlight their functional and structural similarities,
these proteins are described here by a single term, ISCU1/2.
ISCU1/2 facilitate the assembly of [4Fe-4S] and [2Fe-2S] iron-
sulfur clusters, prosthetic groups that promote electron trans-
port and oxidation-reduction reactions integral to numerous
cellular processes, including ribosome biogenesis, purine catab-
olism, heme biosynthesis, DNA repair, and iron metabolism,
among others (Rouault and Tong, 2008). In particular, iron-sulfur
clusters are incorporated into enzymes that are responsible for
mitochondrial respiration and energy production. These include
the enzymatic isoforms of aconitase, which are integral to the
TCA cycle, and the mitochondrial respiratory complexes
(Complexes I, II, and III), which facilitate electron transport
(Rouault and Tong, 2008). Depending upon the level of ambient
oxygen exposure, alteration of these and other iron-sulfur-
dependent mitochondrial activities can lead to distinct down-
stream consequences on ROS production and cellular survival
(Semenza, 2007). Despite their established importance in
these cellular redox reactions, regulation and function of these
critical prosthetic groups in hypoxic mammalian cells are poorly
characterized.
Because of its robust upregulation of miR-210 in response to
hypoxia and its pivotal function in mediating hypoxic effects in
pulmonary vascular tissue, the human pulmonary arterial endo-
thelial cell (HPAEC) was selected as a model cell type to study
the specific functions of miR-210 during hypoxic stress. In doing
so, we identify ISCU1/2 as direct targets for repression by
miR-210. By downregulating expression of ISCU1/2 during
hypoxia, miR-210 decreases the specific activity of prototypical
iron-sulfur enzymes regulating mitochondrial function, mito-
chondrial Complex I and aconitase, leading to downstream
phenotypic consequences integral to the Pasteur effect. As
a result, both miR-210 and ISCU1/2 are identified as important
and essential factors in the regulation of mitochondrial respira-
tion and metabolism during hypoxic stress. These results
augment our fundamental understanding of this critical meta-
bolic event, common to primary mammalian cell types and nearly
all eukaryotes.
RESULTS
MiR-210 Is Robustly Induced by Hypoxia in Primary
and Transformed Cells
Hypoxic stress in cell culture was utilized to screen for quantita-
tive changes in mature forms of miRNA in HPAECs. After expo-
sure of HPAECs to various levels of hypoxia (0.2%–12% O2) for
24 hr as compared with standard nonhypoxic cell-culture condi-
tions (20% O2), miRNA levels were quantified by reverse
transcription and quantitative polymerase chain reaction
(RT-QPCR). This approach was confirmed as a standardized
system of hypoxic stress by the ability to recapitulate changes
in transcript levels of known hypoxia-related genes (data not
shown). To identify a complete profile of upregulated miRNA,
a Taqman Low Density Array (TLDA) card (Applied Biosystems)
was utilized to screen for the expression levels of 365 mature
human miRNA species via RT-QPCR high-throughput amplifica-
tion followed by validation of these results by standard
RT-QPCR. Furthermore, the levels of specific miRNA were274 Cell Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Iassessed if they were previously reported as upregulated by
hypoxia (Kulshreshtha et al., 2008) or by hypoxia-associated
stimuli (such as inflammation).
In HPAECs, only a few miRNAs are induced by greater than
1.5-fold during hypoxia—namely, miR-210 as well as miR-21,
miR-26b, miR-146a, miR-146b, miR-150, and miR-328 (Fig-
ure 1A). Some, but not all, of these miRNA have been identified
in other transformed (Kulshreshtha et al., 2007) or primary endo-
thelial cells (Fasanaro et al., 2008) exposed to hypoxia. Further-
more, in contrast to the other identified miRNA, only miR-210 is
upregulated by hypoxia in a robust (>25-fold increase) (Figure 1A)
and oxygen-dependent manner (Figure 1B) in HPAECs. In fact,
exposure of murine PAECs (MPAECs) to hypoxia leads to
>100-fold upregulation of miR-210 (Figure 1C). Exposure of
human aortic endothelial cells (HAECs) to hypoxia also leads to
>20-fold upregulation of miR-210 (Figure 1C), suggesting this
phenomenon is common to endothelial cells derived from either
the pulmonary or peripheral vasculature. In addition, hypoxic
treatment increases miR-210 in a variety of transformed cell
types (i.e., embryonic kidney, HEK293; colonic adenocarci-
noma, HT-29; breast carcinoma, MCF-7; and promyelocytic
leukemia, HL-60, Figure 1D). Notably, the absolute levels of
miR-210 induced by hypoxia are mostly similar across these
tested cell types (Figure 1E). However, endothelial cell types
and HL-60 cells express particularly low levels of miR-210 during
exposure to 20% O2 (Figure 1E, see Figure S1 available online),
perhaps suggestive of an augmented action of this miRNA in
these cellular contexts when induced by hypoxia. Nonetheless,
while heterogeneity exists in the baseline level of expression
and relative degree of upregulation, hypoxia increases expres-
sion of miR-210 in a variety of both primary and transformed
mammalian cell types, likely reflecting a fundamental and highly
conserved action of this miRNA.
MiR-210 Directly Represses Expression of ISCU1/2
To consolidate the list of putative mRNA targets of miR-210 from
three in silico algorithms (TargetScan, Sanger MiRBase, and
MiRTarget2), only predicted target mRNA with 100% comple-
mentarity to the miR-210 50 seed sequence (positions 2–8)
were considered. We further restricted putative targets to those
potentially associated with the hypoxic cellular response. Using
these criteria, one target was represented in all three of the
above algorithms: the iron-sulfur cluster assembly proteins
ISCU1/2.
To validate this prediction in HPAECs, we found that ISCU1/2
protein levels (Figure 2A), but not mRNA transcript levels
(Figure 2B), are significantly downregulated after exposure to
0.2% O2 as compared with 20% O2. Using gel densitometry,
protein levels of ISCU1/2 on average after hypoxic exposure
are 0.5-fold of expression at 20% O2 (see Figure 2A and Figures
S2A and S2C). Notably, although typical gel electrophoresis
does not routinely resolve the ISCU isoforms due to minimal
size discrepancy, suitable assessment of changes in global
ISCU protein expression can still be appreciated. Comparable
levels of downregulation occur after exposure to 0.2% O2 or
1% O2 (Figure S2A), suggesting a range of physiologically
relevant hypoxic conditions in which this pathway is active
and perhaps a critical range of miR-210 levels that can induce
similar levels of target gene repression. HAECs exhibit similarnc.
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strating this regulatory pathway in endothelial cells derived
from multiple vascular beds. Additionally, ISCU1/2 levels remain
repressed for up to 60 hr of hypoxic exposure (Figure S2C),
reflecting the upregulation of miR-210 under the same condi-
tions (Figure S2B). In contrast to HIF proteins, which increase
during acute hypoxia but are inactivated with chronic hypoxia
(i.e., >24 hr of hypoxia) (Ginouves et al., 2008), miR-210 and
repression of ISCU1/2 display sustained periods of action and
may, therefore, reflect a chronic, rather than transient, adapta-
tion to hypoxia.
Transfection of miR-210 duplexes (denoted as miR-210-D) in
HPAECs was employed to increase intracellular levels of mature
miR-210 in the absence of hypoxia. Similar to the hypoxic
response, when transfected at relatively low transfection con-
centrations (2 nM), miR-210-D decreases ISCU1/2 to nearly
0.3-fold of expression with transfected miR-control duplexes
(miR-Cont-D) (Figure 2A). In this setting, ISCU1/2 transcripts
are decreased to levels that are 0.4-fold of control (Figure S2E).
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Figure 1. MiR-210 Is Uniquely and Robustly
Upregulated by Hypoxia
(A) RT-QPCR demonstrates upregulation of
a unique panel of miRNA in HPAECs during
hypoxia (0.2% O2, black bars) as compared with
standard nonhypoxic cell-culture conditions
(20% O2, hatched bars).
(B) RT-QPCR demonstrates induction of miR-210
in decreasing concentrations of oxygen. Statistical
significance was determined with a one-way
ANOVA and Bonferroni post hoc test.
(C) RT-QPCR demonstrates induction of miR-210
under hypoxia (0.2% O2, black bars) as compared
with 20% O2 (hatched bars) in vascular cell types,
including murine (MPAECs) and human PAECs
(HPAECs), human aortic endothelial cells (HAECs),
and human pulmonary arterial smooth muscle
cells (PASMCs).
(D) In transformed cells, RT-QPCR demonstrates
induction of miR-210 in hypoxia (0.2% O2, black
bar) as compared with 20% O2 (hatched bar).
(E) Relative levels of mature miR-210 are upregu-
lated by 0.2% O2 (black bars) in multiple primary
and transformed cell types as compared with
exposure to 20% O2 (hatched bars). Levels are
based on the formula (2Ct 3 1012). In (A)–(D),
expression of each miRNA under 20% O2 is as-
signed to a fold change of 1, to which hypoxic
expression is compared. In all panels, error bars
reflect SEM; asterisk signifies p < 0.05 (n R 3),
NS signifies pR 0.05 (nR 3).
In contrast, at a lower concentration
of transfected miR-210-D (0.02 nM),
ISCU1/2 are decreased to levels that are
0.6-fold of control, but ISCU1/2 tran-
scripts remain unchanged (Figures S2D
and S2E). Therefore, depending on its
concentration, this miRNA can suppress
ISCU1/2 expression either at the transla-
tional level alone or at the pretranslational
level. Finally, ISCU1/2 expression during
hypoxia was assessed in the setting of antisense inhibition of
miR-210 (AS-210). AS-210 increases ISCU1/2 by 1.65-fold
during hypoxia as compared to AS-Cont and thus substantially
rescues expression nearly to nonhypoxic levels (Figure 2A).
Certainly, other factors independent of miR-210 could also
contribute to the control of ISCU1/2 during hypoxia. Nonethe-
less, through both gain-of-function and loss-of-function assays,
these data demonstrate that miR-210 is necessary and suf-
ficient for the downregulation of ISCU1/2 during hypoxia.
To demonstrate downregulation of ISCU1/2 during HIF-1a
expression in vivo, tissue was analyzed from mice carrying
tamoxifen-dependent, conditionally inactivated von Hippel
Lindau alleles (VHL/), an established model of sustained stabi-
lization of HIF proteins during nonhypoxic, or ‘‘normoxic,’’ condi-
tions (Haase et al., 2001). In comparison to tamoxifen-treated
VHL flox/flox littermate control mice (referred to as ‘‘WT’’),
VHL/ mice demonstrate significantly higher levels of miR-
210 in kidney, liver, and heart (Figure 2C), corresponding with
elevated HIF-1a expression (Young et al., 2008). Importantly,Cell Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc. 275
Cell Metabolism
MiR-210 Controls Mitochondrial MetabolismISCU1/2
Actin
0
.2
%
 O
2
0.2% O
2
2
0
%
 O
2
 20% O
2
m
iR
-2
1
0
-D
m
iR
-C
o
n
t-
D
A
S
-2
1
0
A
S
-C
o
n
t
0.0
0.2
0.4
0.6
0.8
1.0
 0.2% O
2
 20% O
2
ISCU1/2 Expression (HPAEC)
0.0
0.2
0.4
0.6
0.8
1.0
 miR-210-D
 miR-Cont-D
20% Oxygen
Kidney Liver Heart
0
5
10
15
40
50
F
o
l
d
 
C
h
a
n
g
e
(Tissue)
VHL -/- 
VHL WT*
*
*
ISCU1/2
Actin
Kidney Liver Heart
VHL –/– WT
0
5
10
15
20
D
e
n
s
it
o
m
e
tr
y
(
A
r
b
it
r
a
r
y
 U
n
it
s
)
Kidney
0
5
10
15
20
25 VHL -/-
VHL WT
0
2
4
6
8
10
VHL -/-
VHL WT
VHL -/-
VHL WT
D
e
n
s
it
o
m
e
tr
y
(
A
r
b
it
r
a
r
y
 U
n
it
s
)
D
e
n
s
it
o
m
e
tr
y
(
A
r
b
it
r
a
r
y
 U
n
it
s
)
psicheck-ISCUpsicheck-cont
0
20
40
60
80
N
o
r
m
a
li
z
e
d
 
R
e
n
i
l
l
a
L
u
c
if
e
r
a
s
e
 A
c
t
iv
it
y
(
A
r
b
it
r
a
r
y
 U
n
it
s
)
 
Reporter Construct
 plenti-210
 plenti-cont
* SN
A
D
B
E
miR-210 Expression
0.0
0.4
0.8
1.2
1.6
 AS-210
 AS-Cont
0.2% Oxygen
* * *
1
Littermate Pairs
2 3 1
Littermate Pairs
2 31
Littermate Pairs
2 3
Liver Heart
ISCU1/2 Expression (HPAEC) ISCU1/2 Expression (HPAEC)
D
e
n
s
it
o
m
e
t
r
y
(
A
r
b
i
t
r
a
r
y
 
U
n
i
t
s
)
D
e
n
s
it
o
m
e
t
r
y
(
A
r
b
i
t
r
a
r
y
 
U
n
i
t
s
)
D
e
n
s
it
o
m
e
t
r
y
(
A
r
b
it
r
a
r
y
 U
n
it
s
)
–/– WT –/– WT
C
0.0
0.2
0.4
0.6
0.8
1.0
 0.2% O
2
 20% O
2
F
o
ld
 C
h
a
n
g
e
ISCU1/2 Transcript Levels
SN
(HPAEC)
(HPAEC)
ISCU1/2 Expression
Figure 2. MiR-210 Recognizes ISCU1/2 as Direct Targets for Repression
(A) Western blot/gel densitometry analyses in HPAECs reveal downregulation of ISCU1/2 in 0.2% O2 (black bar) as compared to 20% O2 (gray bar). ISCU1/2 is
repressed by miR-210 duplexes (miR-210-D, gray bar) as compared with control miRNA duplexes (miR-Cont-D, white bar). During hypoxia (0.2% O2), inhibition of
miR-210 (AS-210, black bar) upregulates ISCU1/2 as compared with antisense control (AS-Cont, gray bar).
(B) RT-QPCR demonstrates no change in transcript levels of ISCU1/2 in HPAECs exposed to 0.2% O2 (black bar) as compared with 20% O2 (gray bar).
(C) RT-QPCR demonstrates induction of miR-210 in murine kidney, liver, and heart tissue carrying inactivated VHL (VHL/) (gray bars, n = 3 mice) as compared
with VHL WT tissue (white bars, n = 3 mice). The level of miR-210 in each VHL WT tissue is assigned to a fold change of 1, to which expression in VHL/ tissue is
compared.
(D) Gel densitometry of western blots reveals downregulation of ISCU1/2 protein in tissue derived from three littermate pairs of VHL/ (gray bars) and VHL WT
(white bars) mice. A representative western blot is shown.
(E) COS7 cells were cotransfected with either reporter construct, psicheck-ISCU or psicheck-cont, along with expression plasmids encoding for either miR-210
(plenti-210, gray bars) or negative control (plenti-cont, white bars). MiR-210 (plenti-210) reduces Renilla luciferase activity as compared with control (plenti-cont)
in the setting of psicheck-ISCU but induces no significant change in the setting of psicheck-cont. Error bars reflect SEM; asterisk signifies p < 0.05 (nR 3), NS
signifies p R 0.05 (n R 3). Western blots are representative of experiments performed at least in triplicate; gel densitometry is normalized to actin levels and
compared as arbitrary units.276 Cell Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc.
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expression in kidney, liver, and heart as compared with VHL
WT mice (Figure 2D). Variability in the level of downregulation
among littermate pairs likely reflects variation in the degree of
VHL inactivation after tamoxifen exposure (Minamishima et al.,
2008). Nonetheless, taken together with the mechanistic data
in Figure 2A and Figure S2, these data reflect the in vivo rele-
vance of this HIF-dependent and miR-210-dependent repres-
sion of ISCU1/2.
To prove that miR-210 directly recognizes the identical pre-
dicted target site in the 30UTR of ISCU1 and ISCU2, that target
sequence was cloned into the 30UTR of a Renilla luciferase
reporter vector (psicheck-2, Promega) to generate psicheck-
ISCU. COS7 cells were transfected with psicheck-ISCU or
a control (psicheck-cont) without a miR-210 target sequence.
In each case, these cells were cotransfected with either expres-
sion vectors encoding for miR-210 (plenti-210) or control (plenti-
cont). Renilla luciferase activity was measured and normalized
to the firefly luciferase signal, separately encoded in the psi-
check-2 parent vector. MiR-210 (plenti-210) significantly down-
regulates Renilla luciferase activity as compared to control
(plenti-cont) in the presence of psicheck-ISCU. In contrast,
Renilla luciferase activity is not significantly altered in the pres-
ence of psicheck-cont (Figure 2E). Similarly, during hypoxia
when endogenous miR-210 is upregulated, Renilla luciferase
activity is more robustly repressed when driven by psicheck-
ISCU (AS-Cont) as compared with psicheck-cont (AS-Cont).
Demonstrating the essential role of miR-210 in this response,
inhibition of miR-210 (AS-210) during hypoxia increases Renilla
luciferase activity encoded by psicheck-ISCU, rescuing activity
nearly back to the level driven by psicheck-cont (AS-Cont)
(Figure S2F). Taken together with the bioinformatic predictions
and the downregulation of endogenous ISCU1/2 by miR-210,
these results demonstrate that miR-210 represses gene expres-
sion by recognizing the predicted target sequence in the 30UTR
of ISCU1/2.
Disruption of the Integrity of Iron-Sulfur Clusters
in VHL/ Murine Tissue
Because ISCU1/2 are essential for the biogenesis of iron-sulfur
clusters in vivo, miR-210 and HIF-1a would be expected to
decrease levels of these clusters during hypoxia via downregula-
tion of ISCU1/2. To determine if a HIF-dependent mechanism,
such as miR-210 upregulation, can modulate the integrity of
iron-sulfur clusters, electron paramagnetic resonance (EPR)
spectroscopy was performed to quantify iron-sulfur cluster
levels in intact cells. Owing to high levels of mitochondrial and
iron-sulfur cluster content, murine liver, heart, and kidney tissue
were selected for analysis by EPR. VHL/ liver tissue (n = 3
mice) displays an EPR spectroscopic signal with a peak-to-
peak amplitude (g = 1.93, representing intact iron-sulfur clusters)
that is nearly 45% lower than that seen in VHL WT tissue (n = 3
mice) (Figure 3A). Comparable decreases are also noted in
VHL/ heart (mean decrease of 43.3%, n = 2 mice) and VHL/
kidney (mean decrease of 45.7%, n = 2 mice) tissue as
compared with WT tissue (n = 2 mice). As a result, VHL- and
HIF-dependent mechanisms increase miR-210, decrease
ISCU1/2, and consequently disrupt intact iron-sulfur cluster
levels in vivo.CelMiR-210 Disrupts the Activity of Iron-Sulfur
Cluster-Dependent Metabolic Proteins
To explore a link between miR-210 and the activity of prototyp-
ical iron-sulfur enzymes controlling metabolism, regulation of
aconitase activity by miR-210 was assessed. In HPAECs, miR-
210-D leads to a nearly 40% reduction in the specific activity
of aconitase (Figure 3B). Conversely, inhibition of miR-210
(AS-210) during hypoxia increases the specific activity of aconi-
tase by greater than 60%, as compared with antisense control
(AS-Cont) (Figure 3D), thus demonstrating that endogenous
miR-210 represses aconitase activity during hypoxia. Notably,
miR-210-D induces negligible changes in protein levels of either
isoform of aconitase (IRP-1/cytoplasmic aconitase or ACO-2/
mitochondrial aconitase) over a time frame of 48 hr posttransfec-
tion (Figure 3C). Therefore, correlating with the known function of
ISCU1/2 in maintaining the iron-sulfur clusters in aconitase (Tong
and Rouault, 2006) and the disruption of iron-sulfur clusters in
miR-210-positive tissue (Figure 3A), this disruption of aconitase
activity likely results from miR-210- and ISCU-dependent
repression of iron-sulfur cluster biogenesis and integrity.
To ascertain a link between miR-210 and activity of mitochon-
drial iron-sulfur proteins essential for electron transport, Complex
I activity was assessed, given its dependence on multiple iron-
sulfur clusters for proper function (Hinchliffe and Sazanov,
2005). In HPAECs, miR-210-D decreases the specific activity of
Complex I by 25% (Figure 3E) and does so in the absence of
expression changes of a representative component of Complex
I, NDUFA9 (Figure 3F). In correlation, hypoxia decreases specific
activity of Complex I by 30%, as compared with exposure to 20%
O2 (Figure 3G). Repression of Complex I activity is abolished by
inhibition of miR-210 (AS-210). Thus, miR-210 is necessary and
sufficient to disrupt Complex I activity during hypoxia. These
data again suggest that disruption of iron-sulfur cluster assembly,
independent of downregulation of Complex I subunit expression,
likely drives the decrease of electron transport activity.
MiR-210 and ISCU1/2 Control Identical Downstream
Metabolic Functions
Under normoxic conditions, disruption of Complex I activity and
mitochondrial electron transport leads to direct downstream
functional consequences on energy production, including
decreased oxygen consumption, decreased oxidative phos-
phorylation (OXPHOS), and reduced ATP generation. Corre-
spondingly, in 20% O2, transfection of miR-210-D leads to an
approximate 25% decrease in total oxygen consumption
(Figure 4A) in HPAECs and an approximate 18% decrease in
free ATP levels (Figure 4C). The degree of alteration in these
parameters is consistent with the dependence of cultured endo-
thelial cells on OXPHOS for a minority of total ATP production
(Mann et al., 2003). In correlation, after transfection of RNAi
(si-ISCU), which represses ISCU1/2 expression in HPAECs
(data not shown), similar phenotypes are induced, independent
of the presence of miR-210 (Figures 4B and 4D). Thus, miR-210
and ISCU1/2 control similar functions in maintaining mitochon-
drial respiration and energy production.
In addition to direct regulation of mitochondrial metabolism,
disruption of the balance of electron transport relative to the
intracellular levels of oxygen can affect apoptotic potential and
ROS production (Semenza, 2007). Under normoxia, alterationl Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc. 277
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Figure 3. Direct Disruption of Iron-Sulfur Clusters in VHL/ Tissue In Vivo Correlates with miR-210-Dependent Repression of Iron-Sulfur
Cluster Enzyme Activities in HPAECs
(A) EPR spectroscopy at 15K of miR-210-positive VHL/ liver tissue (dotted line) reveals a decrease in the peak-to-peak amplitude of the iron-sulfur cluster
signal (g = 1.93) as compared with VHL WT murine liver tissue (solid line). The spectroscopic signal in VHL/ liver tissue (n = 3 mice) is nearly 45% lower
than that measured in VHL WT liver tissue (n = 3 mice) (bar graph).
(B) Specific activity of aconitase in HPAECs is decreased by nearly 40% by miR-210-D (2 nM, gray bar) as compared to miR-Cont-D (2 nM, white bar).
(C) As measured by western blot (48 hr posttransfection), miR-210-D (2 nM) does not alter protein expression of IRP-1/cytoplasmic aconitase or ACO-2/
mitochondrial aconitase, as compared to miR-Cont-D (2 nM).
(D) During hypoxia (0.2% O2), inhibition of miR-210 (AS-210, black bar) increases the specific activity of aconitase by >60%, as compared with antisense control
(AS-Cont, gray bar).
(E) MiR-210-D (2 nM, gray bar) represses Complex I activity by approximately 25%, as compared with miR-Cont-D (2 nM, white bar).
(F) As measured by western blot, miR-210-D (2 nM) does not significantly alter protein expression of mitochondrial Complex I protein NDUFA9, as compared to
miR-Cont-D (2 nM).
(G) In the presence of control antisense inhibitor (AS-Cont), hypoxia (black bar) induces an approximately 30% decrease in Complex I activity as compared with
20% O2 (white bar). Inhibition of miR-210 (AS-210) abrogates this effect. Error bars reflect SEM; asterisk signifies p < 0.05 (nR 3), NS signifies pR 0.05 (nR 3). All
blots are representative of experiments performed at least in triplicate.278 Cell Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc.
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MiR-210 Controls Mitochondrial Metabolismof the delivery of electrons in mitochondria, either by pharmaco-
logic inhibitors of electron transport (i.e., rotenone) (Wolvetang
et al., 1994) or by disruption of iron-sulfur clusters in the mito-
chondrial complexes themselves (Napoli et al., 2006), leads to
increased apoptosis and increased ROS flux. Accordingly, in
20% O2, miR-210-D increases apoptotic caspase-3,7 activity
in full growth media (Figure 4E), while it further increases cas-
pase activity (Figure 4E) and annexin V staining (Figure 4G) to
a greater extent when serum and growth factors are withheld.
Furthermore, miR-210-D increases ROS flux, as reflected by
increased fluorescent staining by the oxidant-sensitive fluoro-
phore, DCFDA (Figure 4H). Again, similar phenotypes are
induced by RNAi repression of ISCU1/2 independent of miR-
210 (Figures 4F and 4H). Therefore, these multiple functions of
miR-210 and ISCU1/2 appear convergent, being associated
with perturbations in iron-sulfur-dependent aspects of mito-
chondrial electron transport and respiration.
The miR-210-ISCU1/2 Regulatory Pathway Is Active
in Transformed Cells
Similar to the results with primary endothelial cells and VHL/
tissue, hypoxia upregulates miR-210 (Figure 1) and downregu-
lates ISCU1/2 in numerous transformed cell types (Figure S3A).
Upon further interrogation of HEK293 cells, we found that miR-
210-D represses mRNA (Figure S3B) and protein expression
(Figure S3C) of ISCU1/2. Mirroring its effects in HPAECs,
miR-210-D represses Complex I activity in HEK293 cells by
over 35% (Figure S3D) and, in turn, decreases total oxygen
consumption by nearly 40% (Figure S3E). Therefore, the
miR-210-ISCU1/2 axis represents a regulatory pathway shared
among differing cell types, likely reflecting its fundamental
importance in cellular metabolism during hypoxic stress.
Repression of ISCU1/2 Is Necessary for miR-210
to Control Mitochondrial Metabolism
Finally, to demonstrate that the above cellular functions controlled
by miR-210 are directly caused by repression of ISCU1/2, alter-
ation of these phenotypes by miR-210 was assessed during
constitutive expression of ISCU1/2. To do so, separate lentiviral
constructs were made that carry either a hemagglutinin-tagged
ISCUI-HA or a myc epitope-tagged ISCU2 (ISCU2-myc), but
neither with an intact 30UTR and, thus, missing a miR-210 target
sequence (Tong and Rouault, 2000). While endogenous ISCU1/
2 is downregulated by miR-210-D in HPAECs, protein expression
of ISCU1-HA and ISCU2-myc appears unaffected by miR-210-D,
consistent with the importance of the 30UTR target sequence for
gene repression (Figure 5A). In correlation, while miR-210-D
decreases both aconitase and Complex I activities in the pres-
ence of control GFP expression, miR-210-D induces no signifi-
cant change in these enzymatic activities in the presence of
constitutive expression of ISCU1-HA and ISCU2-myc (Figures
5B and 5C). Conversely, while induction of miR-210 in 0.2% O2
decreases Complex I activity as compared to 20% O2 in GFP-ex-
pressing HPAECs, hypoxia has negligible effects on Complex I
activity during constitutive expression of ISCU1-HA and ISCU2-
myc (Figure 5D). As a result, repression of ISCU1/2 is necessary
and essential for downregulating both aconitase and Complex I
activity via miR-210. Furthermore, while miR-210-D decreases
ATP, constitutive expression of ISCU1-HA and ISCU2-mycCelreverses this change in ATP levels (Figure 5E). Induction of
apoptotic caspase-3,7 activity by miR-210-D is also significantly
decreased by constitutive expression of ISCU1-HA and ISCU2-
myc (Figure 5F) yet not fully reversed after longer periods of expo-
sure to miR-210-D (Figure 5G). Similar to the upstream effects on
aconitase and Complex I activity, downregulation of ISCU func-
tion as a whole is necessary for controlling the downstream
effects of miR-210 on repressing ATP levels and, at least in
part, increasing apoptotic potential. Taken together, these data
establish a causative role for ISCU1/2 in miR-210-dependent
actions, integral to the repression of mitochondrial respiration
that defines the Pasteur effect.
DISCUSSION
Teleological Significance of the miR-210-ISCU1/2
Pathway on Hypoxic Metabolic Regulation
Based on these data, we conclude that miR-210 downregulates
expression of ISCU1/2during hypoxia inorder to represskey meta-
bolic processes that predominate in the Pasteur effect, including
mitochondrial electron transport and the TCA cycle (Figure 6).
The elucidation of the miR-210-ISCU1/2 regulatory pathway
substantially clarifies the nature of the complex crosstalk between
HIF-1a and mitochondria (Seagroves et al., 2001) and comple-
ments other HIF-dependent processes proposed to regulate the
mismatch of reduced oxygen tension and mitochondrial electron
transport. First, by induction of PDK1, HIF-1a decreases the
activity of the TCA cycle, increases glycolysis, and reduces mito-
chondrial electron flux (Kim et al., 2006). Second, HIF-1a induces
a COX4-1 to COX4-2 subunit switch during hypoxia to improve
the efficiency of electron transfer to oxygen at Complex IV (Fukuda
et al., 2007). By targeting the function of iron-sulfur cluster-depen-
dent enzymes in both the TCA cycle (aconitase) and the electron
transport chain (Complex I), miR-210 and ISCU1/2 provide over-
lappingcontrol over thismetabolic switch. Thus, these coordinated
changes allow HIF-1a to manipulate multiple targets and ensure
precise, fail-safe control over energy production and cellular
survival during hypoxic stress (Semenza, 2007).
Identification of this pathway also indicates that disruption of
iron-sulfur clusters themselves is likely an essential feature of
this metabolic transition in hypoxia. Our current in vivo knowl-
edge of deficient iron-sulfur cluster biogenesis in mammalian
cells is indirect, based mostly on studies of frataxin, a protein
that cooperates with ISCU2 in mitochondrial iron-sulfur cluster
synthesis. Studies in frataxin-deficient mice (Thierbach et al.,
2005) have revealed its critical role in augmenting OXPHOS
and altering iron homeostasis. In correlation, a mutation in
ISCU1/2 has recently been linked to a human genetic syndrome
leading to myopathy and lactic acidosis (Mochel et al., 2008).
When interpreted together with the data presented here, these
convergent lines of evidence indicate that not only does
ISCU1/2 regulate mitochondrial respiration and metabolism
but also that such control during hypoxia likely relies upon main-
tenance of iron-sulfur cluster integrity. The characterization of
this type of prosthetic group as a key determinant of this meta-
bolic shift during hypoxia correlates with the known function in
bacteria of iron-sulfur clusters as intracellular sensors of oxygen
(Lazazzera et al., 1996). In mammalian cells, it is possible that
a combination of acute sensitivity of iron-sulfur cluster integrityl Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc. 279
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Figure 4. MiR-210 and ISCU1/2 Control Identical Mitochondrial Metabolic Functions in HPAECs
(A) MiR-210-D (2 nM, gray bar) represses oxygen consumption as compared with miR-Cont-D (2 nM, white bar) by nearly 25%.
(B) Inhibitory RNA recognizing ISCU1/2 (si-ISCU, 40 nM, black bar) represses oxygen consumption by nearly 30% as compared with inhibitory RNA control (si-
Cont, 40 nM).
(C) MiR-210-D (2 nM, gray bar) downregulates free levels of ATP by approximately 18%.
(D) Inhibitory si-ISCU (40 nM, black bar) downregulates free ATP levels by >40%.280 Cell Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc.
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MiR-210 Controls Mitochondrial Metabolismto oxidative stress (Beinert et al., 1997), along with repression of
iron-sulfur cluster biogenesis via downregulated ISCU1/2, may
provide a real-time redox-sensitive ‘‘switch’’ that is triggered
by hypoxia to induce downstream metabolic changes. As
a result, a connection linking miR-210 and ISCU1/2 to hypoxia
and mitochondrial respiration is logical from a teleological
perspective, relying upon the well-conserved iron-sulfur cluster
moiety to act as a direct switch that signals for shifts in aerobic
respiration.
Although the miR-210-ISCU1/2 regulatory mechanism is
active in various cell types, cellular context likely still influences
how this pathway is utilized. For example, in contrast to nontrans-
formed cell types, tumor cells display elevated rates of glycolysis
and repressed rates of OXPHOS during normoxia (the ‘‘Warburg
effect’’). It is an intriguing possibility that the miR-210-ISCU1/2
pathway may influence both the Pasteur effect as well as the War-
burg effect, especially in renal tumors that constitutively express
HIF-1a under normoxia. Additionally, miR-210 is specifically
induced by HIF-1a but not HIF-2a (Camps et al., 2008), a second
transcriptional regulator of the hypoxic response, which carries
partial but not full redundancy in function with HIF-1a (Wang
et al., 2005). As a result, miR-210 may not be upregulated to
robust levels in all tissue types, especially in those where HIF-
1a expression is diminished and HIF-2a predominates (Sowter
et al., 2003). In those cases, other putative HIF-dependent
miRNA may regulate iron-sulfur cluster biology. Alternatively,
miR-210 may modulate metabolic functions via alternative but
synergistic mechanisms independent of ISCU1/2. Thus, it may
prove worthwhile to validate other in silico predicted targets of
miR-210 or HIF-induced miRNA that could work in concert with
ISCU1/2 or its protein partners to control iron-sulfur cluster integ-
rity for more efficient metabolism and energy production.
Additional Implications of Disrupted Iron-Sulfur Cluster
Biogenesis during Hypoxia
In addition to mitochondrial metabolism, the miR-210-ISCU1/2
axis may regulate other hypoxia-dependent and iron-sulfur
cluster-dependent processes. These may include iron metabo-
lism, which is controlled by ISCU1/2 activity (Tong and Rouault,
2006) and hypoxia (Meyron-Holtz et al., 2004) via mechanisms
that have only been partially delineated. Furthermore, hypoxic
repression of mitochondrial function by miR-210 and ISCU1/2
carries the theoretical potential to trigger mitophagy—a form of au-
tophagy in which defective mitochondria are selectively delivered
to lysosomes for degradation. Mitophagy has been characterized
as a HIF-dependent mechanism (Zhang et al., 2008). It remains to
be seen if miR-210 itself induces such mitophagy and if that would
lead to further adaptive or degenerative processes.
The control of apoptosis and ROS flux by the miR-210-
ISCU1/2 pathway may offer insight into the complex processesCelby which ROS levels are regulated by hypoxia. It has been
proposed that hypoxia initially upregulates mitochondrial ROS
flux and consequently induces HIF-1a due to a mismatch of elec-
tron transport and decreased oxygen partial pressure. Upon
induction of HIF-1a and HIF-dependent compensatory mecha-
nisms, however, repression of electron transport corrects the
mismatch with reduced oxygen tension, thereby decreasing
ROS production, decreasing apoptosis, and optimizing energy
production in the hypoxic cell (Semenza, 2007). Based on this
model, the repression of ISCU1/2 and iron-sulfur cluster biogen-
esis by miR-210 duringnormoxiawould create a mismatch in elec-
tron transport and oxygen concentration that leads to an increase
in toxic ROS production and increased apoptosis, as corroborated
by our data (Figures 4E–4H). In contrast, during hypoxia, miR-210
should induce a decrease of ROS flux by acting as a homeostatic
mechanism to relieve, rather than aggravate, such a mismatch of
electron transport and oxygen concentration. In corroboration,
inhibition of miR-210 in HPAECs appears to increase ROS flux
after hypoxic exposure (Figure S4A) and to decrease ATP levels
as compared with antisense control (Figure S4B), indicating an
adaptive role for this miRNA during hypoxic stress. Notably,
apoptotic caspase activity (Figure S4C) and cell viability
(Figure S4D) of HPAECs are not significantly affected by inhibiting
miR-210 under these cell-culture conditions of hypoxia. Only
under extreme stress of growth factor and serum deprivation in
the setting of hypoxia does inhibition of miR-210 induce a modest
increaseof caspase-3,7 signaling and a correlative decrease incell
viability (Figures S4E and S4F). These subtle effects on cell survival
likely reflect the activity of additional compensatory mechanisms
to maintain cell viability, which may be especially prominent in
the HPAEC, a cell type that is exceptionally resistant to hypoxia-
induced cell death (Tretyakov and Farber, 1995). Nonetheless,
when interpreted with other studies demonstrating the repression
of apoptosis by miR-210 during hypoxia in other cellular contexts
(Fasanaro et al., 2008; Kulshreshtha et al., 2007), these data lend
credence to a model in which miR-210 carries a maladaptive
role during normoxia, causing a mismatch of ambient oxygen
and electron transport, but an adaptive role during hypoxia due
to the homeostatic correction of the imbalance of electron trans-
port and oxygen exposure.
Complete understanding of this action of miR-210 is nonethe-
less difficult. While our data suggest a minimal change in ROS
levels after hypoxic exposure of HPAECs (Figure S4A), contro-
versy exists as to whether hypoxia decreases or increases ROS
flux in the pulmonary vasculature, given the technical hurdles of
accurately assessing these oxygen species under low oxygen
tension (Moudgil et al., 2005). Furthermore, if miR-210 alterna-
tively regulates iron metabolism or preferentially allows for
release of free iron from modified iron-sulfur clusters during
hypoxia (Beinert et al., 1997), redox-sensitive iron species may(E) MiR-210-D (2 nM, gray bar) induces apoptotic caspase-3,7 activity by >5-fold compared with miR-Cont-D in HPAECs cultured in full growth media; similarly,
miR-210-D increases caspase-3,7 activity by >5-fold compared with miR-Cont-D in basal media (without added growth factors or serum) and by >50-fold
compared with miR-210-D in full growth media.
(F) Inhibitory si-ISCU (40 nM, black bar) upregulates caspase-3,7 activity by >2-fold under full growth media.
(G) When cultured in basal media and exposed to annexin V-fluorescein, miR-210-D (2 nM) increases fluorescent staining in HPAECs as compared with miR-
Cont-D (2 nM).
(H) MiR-210-D (2 nM) increases fluorescent staining in HPAECs by the oxidant-sensitive fluorophore DCFDA, as compared with miR-Cont-D (2 nM). Transfection
of si-ISCU (40 nM) also increases fluorescent staining by DCFDA, as compared with si-Cont (40 nM). All fluorescent mages were acquired under a green filter
(516 nm). Error bars reflect SEM; asterisk signifies p < 0.05 (nR 3), NS signifies pR 0.05 (nR 3).l Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc. 281
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Figure 5. Constitutive Expression of ISCU1 and ISCU2 Inhibits the Action of miR-210 on Iron-Sulfur Cluster-Dependent Metabolic Functions
(A) Western blot/gel densitometry demonstrates that miR-210-D downregulates ISCU1/2 expression (lower bands) as compared with control; in contrast, no
change in protein levels is induced by miR-210-D of 30UTR-deficient ISCU1-HA (HA-tagged) or ISCU2-myc (myc-tagged). Gel densitometry is normalized to actin
levels. Expression levels with miR-Cont-D are assigned to a fold change of 1 (white bars), to which levels with miR-210-D (gray bars) are compared. Blots are
representative of experiments performed in triplicate.
(B and C) As compared with miR-Cont-D (2 nM, white bars), miR-210-D (2 nM, gray bars) decreases specific activities of aconitase (B) and Complex I (C) in GFP-
expressing HPAECs; in contrast, miR-210-D induces no significant alteration of enzyme activities in the presence of constitutively expressed ISCU1/2 (ISCU1-
HA+ISCU2-myc).
(D) As compared with 20% O2 (gray bars), Complex I activity is decreased in 0.2% O2 (black bars) in GFP-expressing HPAECs (GFP). This hypoxic repression is
abrogated by constitutive expression of ISCU1/2 (ISCU1-HA+ISCU2-myc).
(E) MiR-210 (2 nM, gray bars) decreases free ATP levels as compared with miR-Cont-D (2 nM, white bars) in GFP-positive HPAECs; this effect is abrogated by
constitutively expressed ISCU1/2 (ISCU1-HA+ISCU2-myc).282 Cell Metabolism 10, 273–284, October 7, 2009 ª2009 Elsevier Inc.
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MiR-210 Controls Mitochondrial Metabolismserve as additional sources of ROS generation, independent of
the activity of mitochondrial electron transport. As a result, future
and more definitive studies will be critical for defining the effects
of miR-210 on the control of ROS generation. This experimental
direction will be particularly important in the endothelium, owing
to the importance of potential ROS-dependent phenotypes, such
as permeability, thrombosis, vasomotor tone, and angiogenesis.
In conclusion, we identify miR-210 and ISCU1/2 as critical
regulatory factors in hypoxia that control mitochondrial respira-
tion and thus modulate a fundamental shift in cellular metabolism.
Consequently, these data should serve as a foundation for
studies designed to explore further the actions of miR-210 and
other hypoxia-induced miRNA on mitochondria and metabolism,
additional functions of iron-sulfur cluster biology in hypoxia, and
the more complex effects of miR-210 and ISCU1/2 in vivo under
physiological and hypoxia-dependent disease states.
EXPERIMENTAL PROCEDURES
Cells
Primary HPAECs and human PASMCs were purchased and propagated in
EGM-2 and SmGM-2 media, respectively (Lonza). Experiments were per-
formed at passages 5–9. COS7, HEK293, MCF-7, and HT-29 cells were grown
in DMEM with 10% serum. HL-60 cells were grown in RPMI1640 with 4 mM
L-glutamine and 10% serum.
Exposure to Hypoxia
HPAECs were exposed for 24 hr (unless otherwise stated) either to standard
nonhypoxic cell-culture conditions, (20% O2, 5% CO2, with N2 balance at
37C) or to hypoxia (0.2%–12% O2, 5% CO2, with N2 balance at 37C), in either
a modular hypoxia chamber or a tissue culture incubator. Conditions were
based on studies of hypoxic exposure of HPAECs (Manalo et al., 2005) to allow
for steady-state adaptation without nonspecific cell death.
(F) Thirty-six hours after transfection, miR-210-D (2 nM, gray bars) induces >3-fold upregulation of apoptotic caspase-3,7 activity in HPAECs expressing GFP as
compared with miR-Cont-D (2 nM, white bars); no change in caspase-3,7 activity is induced by miR-210-D in HPAECs constitutively expressed ISCU1/2 (ISCU1-
HA+ISCU2-myc).
(G) Fifty-four hours after transfection, miR-210-D (2 nM, gray bars) induces a >3-fold increase in caspase-3,7 activity in HPAECs expressing GFP as compared with
miR-Cont-D (2 nM, white bars); miR-210-D (2 nM, gray bars) induces significantly lower caspase-3,7 activity in HPAECs constitutively expressed ISCU1/2 (ISCU1-
HA+ISCU2-myc). Error bars reflect SEM; asterisk signifies p < 0.05 (nR 3), NS signifies pR 0.05 (nR 3).
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Figure 6. MiR-210 Regulates Iron-Sulfur
Cluster-Dependent Metabolic Function dur-
ing Hypoxia
A molecular model is presented whereby the
hypoxia-induced miR-210 directly represses
expression of ISCU1/2 to downregulate iron-sulfur
cluster biogenesis and iron-sulfur-dependent
metabolic enzyme activity. In doing so, miR-210
disrupts mitochondrial respiration and potentially
other iron-sulfur cluster-dependent functions
such as iron metabolism and ROS generation. As
a result, miR-210 modulates a unique constellation
of essential metabolic functions that predominate
in the Pasteur effect and influence cellular adapta-
tion to hypoxia in the mammalian cell.
RNA Extraction and RT-QPCR
RNA extraction (miRNeasy kit, QIAGEN) and
reverse transcription of total RNA were performed
to generate cDNA representing levels of either
mRNA (High Fidelity cDNA Amplification Kit,
Applied Biosystems) or mature miRNA molecules
(MicroRNA Assay Kit, Applied Biosystems). Owing to the stem loop structures
of the miRNA primers, only mature miRNA molecules were amplified into
cDNA. cDNA was amplified via fluorescently labeled Taqman probe and
primer sets using an Applied Biosystems 7900HT Fast Real Time PCR device.
Details of high-throughput RT-PCR screening of miRNA are described in the
Supplemental Experimental Procedures.
MicroRNA Overexpression and Repression
Chemically synthesized miRNA duplexes (Ambion) were transfected to mimic
the mature form of miR-210, as compared with control. Oligonucleotides
(Dharmacon) were transfected that carry specific antisense sequences to
miR-210, as compared with control. RNA interference of ISCU1/2 expression
was performed using custom-designed inhibitory RNA (Stealth siRNA from
Invitrogen).
Additional Information
See the Supplemental Experimental Procedures for information on in silico
miRNA target prediction, EPR spectroscopy, animal manipulation, plasmid
construction, lentivirus production, transfection, immunoblotting, and stan-
dardized assays of metabolic and mitochondrial functions, ROS flux, and
cell survival.
Statistical Analysis
Data are presented either as a representative example of a single experiment,
repeated at least in triplicate, or as mean ± standard error of the mean for three
or more experiments. Paired samples were compared by Student’s t test;
multiple comparisons were made with a one-way ANOVA followed by a Bonfer-
roni post hoc test. Values of p < 0.05 are considered significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, and four figures and can be found with this article
online at http://www.cell.com/cell-metabolism/supplemental/S1550-4131(09)
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